Get sufficient sleep, exercise and nutrition
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become a powerful tool for weight loss in recent years
Something else was happening at the level of the blood vessels themselves
Gastrointestinal: Acute pancreatitis, hemorrhagic and necrotizing pancreatitis sometimes resulting in death, ileus General Disorders and Administration Site Conditions: Allergic reactions: rash and pruritus Hepatobiliary: Elevations of liver enzymes, hyperbilirubinemia, cholestasis, cholecystitis, cholelithiasis requiring cholecystectomy, hepatitis Immune system: Angioedema and anaphylactic reactions Metabolism and nutrition: Dehydration resulting from nausea, vomiting and diarrhea Neoplasms: Medullary thyroid carcinoma Nervous system: Dysgeusia, dizziness Pulmonary: Pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation
Buyer Takeaway: Omzo checks the core legitimacy boxes for a compounded GLP-1 telehealth platform in 2026
This does not mean weight alone causes cancer, but it can affect the body in ways that may increase risk